Premium
Montelukast in 2‐to 5‐year‐old children with asthma
Author(s) -
Skoner David
Publication year - 2001
Publication title -
pediatric pulmonology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.866
H-Index - 106
eISSN - 1099-0496
pISSN - 8755-6863
DOI - 10.1002/ppul.2006
Subject(s) - medicine , montelukast , asthma , pharmacokinetics , pediatrics , anesthesia
Pediatric dose selection for montelukast in 2–5‐year‐old children was based on a pharmacokinetic approach that was also used in previously selecting a once‐daily 5‐mg chewable tablet for asthmatic children 6–14 years of age. A 4‐mg chewable tablet administered once daily was determined to be the correct dose and was subsequently found to be safe and effective in asthmatic children 2–5 years of age. Pediatr Pulmonol. 2001; Supplement 21:46–48. © 2001 Wiley‐Liss, Inc.